488 related articles for article (PubMed ID: 24656178)
21. Irreversible electroporation (Nanoknife® treatment) in the field of hepatobiliary surgery: Current status and future perspectives.
Kourounis G; Paul Tabet P; Moris D; Papalambros A; Felekouras E; Georgiades F; Astras G; Petrou A
J BUON; 2017; 22(1):141-149. PubMed ID: 28365947
[TBL] [Abstract][Full Text] [Related]
22. Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.
Barabasch A; Distelmaier M; Heil P; Krämer NA; Kuhl CK; Bruners P
Invest Radiol; 2017 Jan; 52(1):23-29. PubMed ID: 27379698
[TBL] [Abstract][Full Text] [Related]
23. Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.
Fritz S; Sommer CM; Longerich T; Kuhn-Neureuther C; Radeleff B; Werner J; Hackert T
Langenbecks Arch Surg; 2017 May; 402(3):465-473. PubMed ID: 28378237
[TBL] [Abstract][Full Text] [Related]
24. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
[TBL] [Abstract][Full Text] [Related]
25. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
[TBL] [Abstract][Full Text] [Related]
26. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
[TBL] [Abstract][Full Text] [Related]
27. A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma.
Yan L; Chen YL; Su M; Liu T; Xu K; Liang F; Gu WQ; Lu SC
Chin Med J (Engl); 2016 Dec; 129(24):2920-2925. PubMed ID: 27958223
[TBL] [Abstract][Full Text] [Related]
28. [Irreversible electroporation: a new form of image-guided tumour ablation].
Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
[TBL] [Abstract][Full Text] [Related]
29. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.
Niessen C; Beyer LP; Pregler B; Dollinger M; Trabold B; Schlitt HJ; Jung EM; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Apr; 27(4):480-6. PubMed ID: 26922979
[TBL] [Abstract][Full Text] [Related]
31. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.
Jarm T; Krmac T; Magjarevic R; Kos B; Cindric H; Miklavcic D
Biomed Eng Online; 2020 Nov; 19(1):85. PubMed ID: 33198769
[TBL] [Abstract][Full Text] [Related]
32. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
[TBL] [Abstract][Full Text] [Related]
34. Ablation of hepatic malignant tumors with irreversible electroporation: A systematic review and meta-analysis of outcomes.
Tian G; Zhao Q; Chen F; Jiang T; Wang W
Oncotarget; 2017 Jan; 8(4):5853-5860. PubMed ID: 28009979
[TBL] [Abstract][Full Text] [Related]
35. Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography.
Au JT; Kingham TP; Jun K; Haddad D; Gholami S; Mojica K; Monette S; Ezell P; Fong Y
Surgery; 2013 Jun; 153(6):787-93. PubMed ID: 23489942
[TBL] [Abstract][Full Text] [Related]
36. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
[TBL] [Abstract][Full Text] [Related]
38. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience.
Trimmer CK; Khosla A; Morgan M; Stephenson SL; Ozayar A; Cadeddu JA
J Vasc Interv Radiol; 2015 Oct; 26(10):1465-71. PubMed ID: 26250855
[TBL] [Abstract][Full Text] [Related]
39. Cardiac synchronization and arrhythmia during irreversible electroporation.
O'Neill CH; Martin RCG
J Surg Oncol; 2020 Sep; 122(3):407-411. PubMed ID: 32483842
[TBL] [Abstract][Full Text] [Related]
40. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
Cheng RG; Bhattacharya R; Yeh MM; Padia SA
J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
